Business
CareRx Corporation Receives Regulatory Approval for Launch of its Normal Course Issuer Bid
CareRx Corporation Receives Regulatory Approval for Launch of its Normal Course Issuer Bid ...
About this update from Carerx Corporation
[{"type":"text","content":"\n \n \n \n CareRx Corporation Receives Regulatory Approval for Launch of its Normal Course Issuer Bid\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n \n ,\n \n \n Sept. 5, 2023\n \n \n /CNW/ -\n \n CareRx Corporation\n \n (\"CareRx\" or \"the Company\") (TSX: CRRX) today announced that the Toronto Stock Exchange (the \"TSX\") has approved the Company's previously announced normal course issuer bid (the \"NCIB\") to purchase for cancellation up to 1,000,000 of its common shares (\"Shares\"), representing approximately 1.73% of its 57,743,726 issued and outstanding Shares as at August 31, 2023.\n \n \n It is expected that the NCIB will begin on\n \n September 7, 2023\n \n and will end on September 6, 2024. Daily purchases on the TSX under the NCIB will be limited to 4,624 Shares, other than purchases made pursuant to the block purchase exception, being 25% of the average daily trading volume on the TSX for the six months ending\n \n July 31, 2023\n \n . The actual number of Shares to be purchased, and the timing of any such purchases, will be determined by the Company, subject to the applicable rules and policies of the TSX. All Shares acquired will be cancelled.\n \n \n Although the Company presently intends to purchase Shares under its NCIB, there can be no assurances that any such purchases will be completed. The purchases will be made through the facilities of the TSX and/or any alternative trading system in\n \n Canada\n \n . The Company will pay the market price for the common shares at the time of acquisition and the purchases will be made in accordance with applicable regulatory requirements.\n \n \n \n About CareRx Corporation\n \n \n \n CareRx is\n \n Canada's\n \n leading provider of pharmacy services to seniors living communities. We serve over 95,000 residents in over 1,500 seniors and other congregate care communities (long-term care homes, retirement homes, assisted living facilities, and group homes). We are a national organization with a large network of pharmacy fu...